(0.10%) 5 251.75 points
(0.01%) 39 647 points
(0.20%) 18 292 points
(0.23%) $78.44
(1.24%) $2.28
(-0.85%) $2 354.90
(-0.42%) $28.39
(0.04%) $1 007.60
(-0.03%) $0.928
(0.26%) $10.86
(0.03%) $0.799
(-0.93%) $91.81
Live Chart Being Loaded With Signals
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets...
Stats | |
---|---|
Today's Volume | 13 515.00 |
Average Volume | 572 064 |
Market Cap | 5.76M |
EPS | $0 ( 2024-05-08 ) |
Next earnings date | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.960 |
ATR14 | $0.0400 (1.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-26 | Van Der Baan Bastiaan Jeroen | Buy | 250 000 | Options to Purchase Common Stock |
2023-10-03 | Bernards Rene | Buy | 5 527 | Common Stock |
2023-10-02 | Bernards Rene | Buy | 4 473 | Common Stock |
2023-10-03 | Van Der Baan Bastiaan Jeroen | Buy | 10 000 | Common Stock |
2023-10-02 | Bernards Rene | Buy | 4 473 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 91 transactions |
Buy: 9 375 819 | Sell: 3 494 167 |
Lixte Biotechnology Correlation
10 Most Positive Correlations | |
---|---|
XFOR | 0.888 |
RMRM | 0.887 |
CDXC | 0.886 |
FUSN | 0.883 |
RAIL | 0.883 |
ACTG | 0.877 |
NWLI | 0.873 |
CBAY | 0.871 |
UFPT | 0.87 |
XBIT | 0.87 |
10 Most Negative Correlations | |
---|---|
ISPC | -0.894 |
RMGC | -0.873 |
TRVN | -0.871 |
ACXP | -0.864 |
NLSP | -0.864 |
AEY | -0.86 |
HCDIP | -0.852 |
BTTX | -0.852 |
SBNYP | -0.851 |
RGC | -0.849 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lixte Biotechnology Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.66 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-2.66 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-39.85 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.500 |
Financial Reports:
No articles found.
Lixte Biotechnology
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators